Tuesday, November 26, 2024

Inspections, Recalls, and Other Actions with Respect to Firms that Engage in Animal Drug Compounding

 https://www.fda.gov/animal-veterinary/animal-drug-compounding/inspections-recalls-and-other-actions-respect-firms-engage-animal-drug-compounding

Sep 20, 2024 — Referral Letter to Oklahoma State Board of Pharmacy Issued 02/2

 

5 days ago — The meeting will be held at the FDA White Oak Campus, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002. The public will also have the option to ...

 

5 days ago — NPR hits the GLP-1 nail on the head. A National Public Radio piece this week tackled the issue of compounded GLP-1 drugs and got the facts and nuance just right ...

 

5 days ago — Any nonresident pharmacy or in-state compounding pharmacy without a license that dispenses prescription products into Massachusetts on or after May 1, 2025, ...

 

6 hours ago — “None of these drugs are old enough yet to be generic. They're still all ... A compounded drug is a medicine pharmacies make from scratch. The FDA has ...

 

5 days ago — ... to influence drug pricing, which he says could weaken FDA's ability to regulate compounded drugs and erode its authority over compounding pharmacies.

 

2 days ago — ... drug from U.S. regulations that allow it to be compounded. The FDA said it ... compounded drugs are not tracked in traditional channels. Compounding ...

 

3 days ago — FDA is in a quandary about compounding of the new obesity drugs, semaglutide and tirzepatide. The nominee to lead FDA has an interest.

 

14 hours ago — However, there is controversy swirling around the FDA's recent decision on the drug shortage for GPL-1 obesity medications and the practice of compounding ...

 

1 day ago — "These are powerful medications and right now a consumer can go on the internet and purchase them, even if it's not the right medication for them without any ...